Journal of Bioequivalence & Bioavailability

Journal of Bioequivalence & Bioavailability
Open Access

ISSN: 0975-0851

+32-466-902163

Editorial Board

Sinerik Ayrapetyan
Editor-in-Chief
President, UNESCO Chair-Life Sciences International
Armenia

Michael Retsky
Editor-in-Chief
BioMedical Imaging Laboratory, Harvard School of Public Health
USA

Yulong Yin
Editor-in-Chief
Professor, Institute of Subtropical Agriculture, The Chinese Academy of Science
P.R. China

Submit Manuscript

Submit manuscript at www.longdom.org/submissions/bioequivalence-bioavailability.html or send as an e-mail attachment to the Editorial Office at [email protected]

About the Journal

The Journal of Bioequivalence & Bioavailability (JBB) is an academic journal that encompasses a wide range of current research on FDA Bioequivalence, Bioequivalence antipsychotics, Bioequivalence anticancers, Bioequivalence antidiuretics, Bioequivalence antipsychotics, BA/BE Studies, Biosimilars, Advances in Bioavailability and offers a promising platform for the authors to make their valuable contributions towards the journal.

Journal of Bioequivalence & Bioavailability is the best open access journal that aims to publish most complete and reliable source of information on the discoveries and advanced developments in this field in the form of original articles, review articles, case reports, short communications, etc. and provide free online access to it without any restrictions or any other subscriptions to researchers worldwide. Journal of Bioequivalence & Bioavailability is one of the best Open Access journals of Scholarly publishing.

The Bioequivalence Peer Reviewed Journal is proficiently supported by universally prominent Editorial Board members. Bioequivalence journal impact factor is mainly calculated based on the number of articles that undergo single blind peer review process by competent Editorial Board so as to ensure excellence, essence of the work and number of citations received for the same published articles.

Journal Highlights

Top